Bibliography
- Fast Stats. Inpatient surgery. Centers for Disease Control and Prevention. 2013. Available from: http://www.cdc.gov/nchs/fastats/insurg.htm [Last accessed 16 September 2013]
- Samudrala S. Topical hemostatic agents in surgery: a surgeon's perspective. AORN J 2008;88:S1-11
- Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 2013;112:1506-19
- Cosemans JM, Angelillo-Scherrer A, Mattheij NJ, Heemskerk JW. The effects of arterial flow on platelet activation, thrombus growth and stabilization. Cardiovasc Res 2013. [Epub ahead of print]
- Spotnitz WD. Hemostats, sealants, and adhesives: a practical guide for the surgeon. Am Surg 2012;78:1305-21
- Minato N, Katayama Y, Yunoki J, et al. Hemostatic effectiveness of a new application method for fibrin glue, the "rub-and-spray method", in emergency aortic surgery for acute aortic dissection. Ann Thorac Cardiovasc Surg 2009;15:265-71
- Go P, Goodman GR, Breun EW, Hunter JG. The argon beam coagulator provides rapid hemostasis of experimental hepatic and splenic hemorrhage in anticoagulated dogs. J Trauma 1991;31:1294-300
- Woodworth BA, Chandra RK, LeBenger JD, et al. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery. Am J Otolaryngol 2009;30:49-53
- Galanakis I, Vasdev N, Soomro N. A review of current hemostatic agents and tissue sealants used in laparoscopic partial nephrectomy. Rev Urol 2011;13:131-8
- Reuthebuch O, Lachat ML, Vogt P, et al. FloSeal: a new hemostyptic agent in peripheral vascular surgery. Vasa 2000;29:204-6
- Nasso G, Piancone F, Bonifazi R, et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 2009;88:1520-6
- Oz MC, Cosgrove DM III, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg 2000;69:1376-82
- Achneck HE, Sileshi B, Jamiolkowski RM, et al. A comprehensive review of topical hemostatic agents. Ann Surg 2010;251:217-28
- Jackson MR. Fibrin sealants in surgical practice: an overview. Am J Surg 2001;182:1S-7S
- Spotnitz WD, Prabhu R. Fibrin sealant: tissue adhesive – review and update. J Long Term Med Implants 2005;15:245-70
- Rousou JA. Use of fibrin sealants in cardiovascular surgery: a systematic review. J Card Surg 2013;28:238-47
- Cohen DM, Norberto J, Cartabuke R, Ryu G. Severe anaphylactic reaction after primary exposure to aprotinin. Ann Thorac Surg 1999;67:837-8
- Kaul P. Spontaneous retrograde dissection of ascending aorta from descending thoracic aorta – a case review. Perfusion 2011;26:215-22
- Lowe J, Luber J, Levitsky S, et al. Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study. J Cardiovasc Surg (Torino) 2007;48:323-31
- Christenson JT, Kalangos A. Autologous fibrin glue reinforced by platelets in surgery of ascending aorta. Thorac Cardiovasc Surg 2004;52:225-9
- Stark J, de Leval M. Experience with fibrin seal (Tisseel) in operations for congenital heart defects. Ann Thorac Surg 1984;38:411-13
- Saha S, Muluk S, Schenk W, et al. A prospective randomized study comparing fibrin sealant to manual compression for the treatment of suture hole bleeding in expanded polytetrafluoroethylene grafts. J Vasc Surg 2012;56:134-41
- Malarkey M, Epstein J. April 2, 2010 Approval Letter – TachoSil. U.S. Food and Drug Administration. Available from: http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm207486.htm [Last accessed 15 June 2013]
- Berdajs D, Bürki M, Michelis A, von Segesser LK. Seal properties of TachoSil®: in vitro hemodynamic measurements. Interact CardioVasc Thorac Surg 2010;10:910-13
- Maisano F, Kjærgård HK, Bauernschmitt R, et al. TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial. Eur J Cardiothorac Surg 2009;36:708-14
- Pocar M, Passolunghi D, Bregasi A, Donatelli F. TachoSil® for postinfarction ventricular free wall rupture. Interact Cardiovasc Thorac Surg 2012;14:866-7
- Kuschel TJ, Gruszka A, Hermanns-Sachweh B, et al. Prevention of postoperative pericardial adhesions with TachoSil. Ann Thorac Surg 2013;95:183-8
- Safety and efficacy study of fibrin sealant Grifols evaluated as an adjunct to Hemostasis. Clinical Trials.Gov. Verified March 2013 by Grifols Biologicals, Inc. Available from: http://www.clinicaltrials.gov/ct2/show/results/NCT00684047?term=Study+to+Evaluate+the+Safety+and+Efficacy+of+Fibrin+Sealant+Grifols+%28FS+Grifols%29&rank=1 [Last accessed 4 June 2013]
- Hazelaar S, Dijkstra-Tiekstra MJ, de Korte D, de Wildt-Eggen J. Allogeneic single-donor cryoseal produced from fresh-frozen quarantine apheresis plasma as alternative for multidonor or autologous fibrin sealants. Transfusion 2012;52:517-23
- Buchta C, Hedrich HC, Macher M, et al. Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel. Biomaterials 2005;26(31):6233-41
- Medical Devices. CoSeal® Surgical Sealant - P010022. U. S. Food and Drug Administration. Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm083959.htm [Last accessed 14 June 2013]
- Hill A, Estridge TD, Maroney M, et al. Treatment of suture line bleeding with a novel synthetic surgical sealant in a canine iliac PTFE graft model. J Biomed Mater Res 2001;58:308-12
- Natour E, Suedkamp M, Dapunt O. Assessment of the effect on blood loss and transfusion requirements when adding a polyethylene glycol sealant to the anastomotic closure of aortic procedures: a case – control analysis of 102 patients undergoing bentall procedures. J Cardiothorac Surg 2012;7:105
- Napoleone CP, Oppido G, Angeli E, Gargiulo G. Resternotomy in pediatric cardiac surgery: coSeal® initial experience. Interact CardioVasc Thorac Surg 2007;6:21-3
- Nishimura K, Kimura T, Morita A. Watertight dural closure constructed with DuraSeal™ for bypass surgery. Neurol Med Chir (Tokyo) 2012;52:521-4
- PR Newswire. DuraSeal® sealant receives CE mark for vascular applications. Available from: http://www.prnewswire.com/news-releases/durasealr-sealant-receives-ce-mark-for-vascular-applications-55139392.html [Last accessed 17 September] [2013]
- Adhesives and Sealants.com. DuraSeal® sealant CE mark for thoracic applications. Available from: http://www.adhesivesandsealants.com/doc/durasealr-sealant-ce-mark-for-thoracic-applic-0001 [Last accessed 17 September 2013]
- Klijian A. A novel approach to control air leaks in complex lung surgery: a retrospective review. J Cardiothorac Surg 2012;7:49
- Labenz J, Börsch G. Bleeding and gastric duodenal varicdose veins: endoscopic embolisation using tissue adhesives. Dtsch Med Wochenschr 1992;117:1274-7
- Almeida JI, Min RJ, Raabe R, et al. Cyanoacrylate adhesive for the closure of truncal veins: 60-day swine model results. Vasc Endovascular Surg 2011;45:631-5
- Hewitt CW, Marra SW, Kann BR, et al. BioGlue surgical adhesive for thoracic aortic repair during coagulopathy: efficacy and histopathology. Ann Thorac Surg 2001;71:1609-12
- Leva C, Bruno PG, Gallorini C, et al. Complete myocardial revascularization and sutureless technique for left ventricular free wall rupture: clinical and echocardiographic results. Interact Cardiovasc Thorac Surg 2006;5:408-12
- Passage J, Jalali H, Tam RK, et al. BioGlue surgical adhesive—an appraisal of its indications in cardiac surgery. Ann Thorac Surg 2002;74:432-7
- Elefteriades JA. How i do it: utilization of high-pressure sealants in aortic reconstruction. J Cardiothorac Surg 2009;4:27
- Modi A, Bull R, Tsang G, Kaarne M. Ostial left coronary stenosis following aortic root reconstruction with BioGlue. Interact Cardiovasc Thorac Surg 2011;13:243-5
- LeMaire SA, Schmittling ZC, Coselli JS, et al. Bioglue surgical adhesive impairs aortic growth and causes anastomotic strictures. Ann Thorac Surg 2002;73:1500-6
- Sun JC, Whitlock R, Cheng J, et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J 2008;29:2592-600
- Herman CR, Buth KJ, Kent BA, Hirsch GM. Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. Ann Thorac Surg 2010;89:397-402
- Rodgers GM. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature. J Pediatr Hematol Oncol 2011;33:86-8
- USF Hemostasis: usage of HemCon for femoral hemostasis after percutaneous procedures (USF-Hemostasis). Available from: http://clinicaltrials.gov/show/NCT00716365 [Last accessed 4 September 2013]